MMCAP International’s ZyVersa Therapeutics ZVSA Stock Holding History

MMCAP International’s Portfolio ZVSA Stock Details ZVSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,057	Closed	-$3.7M	–	384
2022 Q3	$3.7M	Hold	1,057	–	–	0.29%	131
2022 Q2	$3.67M	Hold	1,057	–	–	0.29%	135
2022 Q1	$3.68M	Buy	+1,057	New	+$3.66M	0.22%	179

Other funds holding ZVSA

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

MMCAP International's ZVSA Position: Q4 2022 in Review

MMCAP International sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 1,057 shares — an estimated $3.7M sold.

MMCAP International first reported a position in ZVSA in Q1 2022 and held it in 3 quarters. The position peaked at $3.7M in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

MMCAP International reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
MMCAP International sold 1,057 ZyVersa Therapeutics shares in Q4 2022, an estimated $3.7M.
MMCAP International first reported a position in ZyVersa Therapeutics in Q1 2022 and held it in 3 quarters.
MMCAP International's ZyVersa Therapeutics position peaked at $3.7M in Q3 2022.
2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on MMCAP International's 13F filing for Q4 2022, filed 9 Feb 2023.